1 FLUOROURACIL | 30 of 280 | 1480 prescriptions Less than 1% of all prescriptions | | 1380 patients 38% of all patients | < 11 | |
2 TRIAMCINOLONE ACETONIDE | 130 of 350 | 970 prescriptions Less than 1% of all prescriptions | 810 | 560 patients 15% of all patients | < 11 | |
3 KETOCONAZOLE | 60 of 330 | 770 prescriptions Less than 1% of all prescriptions | | 460 patients 13% of all patients | < 11 | |
4 CLOBETASOL PROPIONATE | 100 of 320 | 700 prescriptions Less than 1% of all prescriptions | 530 | 360 patients 10% of all patients | < 11 | |
5 METRONIDAZOLE | 60 of 280 | 330 prescriptions Less than 1% of all prescriptions | | 190 patients 5% of all patients | < 11 | A |
6 IMIQUIMOD | 30 of 70 | 280 prescriptions Less than 1% of all prescriptions | 280 | 210 patients 6% of all patients | 210 patients 6% of all patients | |
7 DOXYCYCLINE HYCLATE | 110 of 220 | 200 prescriptions Less than 1% of all prescriptions | | 160 patients 4% of all patients | < 11 | A |
8 TACROLIMUS | 20 of 60 | 220 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | |
9 BETAMETHASONE DIPROP AUGMENTED (BETAMETHASONE/PROPYLENE GLYC) | 50 of 100 | 310 prescriptions Less than 1% of all prescriptions | | 240 patients 7% of all patients | < 11 | |
10 CALCIPOTRIENE | 40 of 90 | 240 prescriptions Less than 1% of all prescriptions | | 150 patients 4% of all patients | < 11 | |
11 TRETINOIN | 30 of 50 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
12 DUPIXENT (DUPILUMAB) | 10 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
13 JUBLIA (EFINACONAZOLE) | 20 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
14 HALOBETASOL PROPIONATE | 20 of 60 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
15 BETAMETHASONE DIPROPIONATE | 140 of 190 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 MUPIROCIN | 100 of 190 | 110 prescriptions Less than 1% of all prescriptions | | 110 patients 3% of all patients | < 11 | |